Related Experiment Video

Updated: Jun 4, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

[Intensive glucose control in type 2 diabetes: is it harmful, needless or maybe useful in reducing cardiovascular

Agostino Consoli1

  • 1Dipartimento di Medicina Interna e Scienze dell'Invecchiamento, Università degli Studi "G. D'Annunzio", Chieti. consoli@unich.it

Giornale Italiano Di Cardiologia (2006)
|March 3, 2011
PubMed

Insights

Intensive glucose control in type 2 diabetes may not reduce cardiovascular risk and could be harmful. New trials are needed to assess intensive glucose control in younger patients using safer medications.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Metabolic Diseases

Context:

  • Type 2 diabetes is a significant risk factor for cardiovascular disease.
  • Hyperglycemia (high blood sugar) is a key feature of diabetes and is implicated in vascular damage.
  • Previous clinical trials aimed to prove tight glucose control reduces cardiovascular risk but yielded inconclusive or negative results.

Purpose:

  • To critically interpret recent clinical trial results on intensive glucose control in type 2 diabetes.
  • To identify factors that may have confounded the outcomes of these trials, such as patient selection, follow-up duration, hypoglycemia, and pharmacological approaches.
  • To propose recommendations for future research in this area.

Summary:

  • Recent large-scale trials on intensive glucose control for type 2 diabetes failed to demonstrate a reduction in macrovascular complications and suggested potential harm.
  • Factors like patient selection, trial duration, hypoglycemia incidence, and specific drug classes used may have obscured the true benefits of strict glycemic management.
  • The review suggests that future trials should focus on younger type 2 diabetes patients without a history of poor glycemic control and utilize newer anti-diabetic agents that minimize hypoglycemia and weight gain risks.

Impact:

  • Highlights the complex relationship between glucose control and cardiovascular outcomes in type 2 diabetes.
  • Underscores the need for carefully designed clinical trials to establish the efficacy and safety of intensive glycemic management.
  • Informs clinical practice and future research directions for managing cardiovascular risk in diabetic patients.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...